Herpetic Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-05
Clinical Trial Update: Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
This completed postmarketing prospective study evaluated the risk of herpetic infection in melanoma patients treated with IMLYGIC.